17 March 2017 : Original article
Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation
DOI: 10.12659/AOT.901556
Ann Transplant 2017; 22:141-147
HTML version available soon